New combo therapy trial aims to boost red blood cells in blood disorder patients
NCT ID NCT07463820
Summary
This study is testing whether combining the drug luspatercept with one of two other medications works better than luspatercept alone for treating anemia in people with lower-risk myelodysplastic syndrome (MDS). The main goal is to see if these combinations help patients make more of their own red blood cells and reduce their need for blood transfusions. About 270 adults who have not had prior MDS treatment and have symptomatic anemia will be randomly assigned to receive one of the three treatment plans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.